Advice
Medicine discontinued

In April 2021, misoprostol (Mysodelle) was discontinued.

 

Medicine details

Medicine name:
misoprostol (Mysodelle)
SMC ID:
996/14
Indication:

For the induction of labour in women with an unfavourable cervix, from 36 weeks gestation, in whom induction is clinically indicated.

Pharmaceutical company
Ferring Pharmaceuticals Ltd
BNF chapter
Obstetrics, gynaecology, and urinary-tract disorders
Status
Withdrawn
Date advice published
13 October 2014
Additional notes

In April 2021, misoprostol (Mysodelle) was discontinued.

In line with SMC process the SMC advice has been removed from the website.